Skip to search formSkip to main contentSkip to account menu

Ebrantil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Summary. Aim. To evaluate the clinical efficacy of ebrantil used in patients with resistant arterial hypertension (RAH) in Stage… 
2012
2012
The developing callus requires sufficient oxygen and substrate supply. Despite the importance of these processes, we have limited… 
2010
2010
Different bones have different blood supplies, which may influence bone healing. Therefore, elucidation of the mechanisms… 
1996
1996
Urapidil, a new alpha-blocker that peripherally antagonizes postsynaptic alpha 1 receptors and centrally causes a reduction in… 
1990
1990
In 10 patients on chronic haemodialysis treatment for terminal renal failure with hypertension urapidil (Ebrantil) was given in… 
1990
1990
In a cross-over study, the effect of 25 mg urapidil infusion (U, Ebrantil 25, Byk-Gulden, FRG) on serotonin (5HT) metabolism and… 
1985
1985
Urapidil (Ebrantil) is a new antihypertensive agent exerting central and peripheral action which is recognized for the treatment… 
1981
1981
The vasodilating effect of 6-(3-[4-(o-methoxy-phenyl)-piperazin-1-yl]-propylamino)-1,3-dimethyluracil (urapidil, Ebrantil) and… 
1977
1977
Compared to the changes in spontaneous behaviour of mice and rats, 6-(3-[4-(o-methoxyphenyl)-1-piperazinyl]-propyl-amino)-1,3…